Your search returned 68 results.

Results
	1.	Progress in gynecologic cancer. [electronic resource] by Seiden, Michael V Producer: 20090515 In: Seminars in oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma. [electronic resource] by Jain, Angela Seiden, Michael V Producer: 20151103 In: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	BMS-247550 Bristol-Myers Squibb/GBF. [electronic resource] by Lin, Nancy Brakora, Katherine Seiden, Michael Producer: 20030909 In: Current opinion in investigational drugs (London, England : 2000) vol. 4 Availability: No items available. Save to lists Add to cart (remove)
	4.	Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative. [electronic resource] by Roche, Maria Kyriakou, Helena Seiden, Michael Producer: 20070215 In: Current opinion in investigational drugs (London, England : 2000) vol. 7 Availability: No items available. Save to lists Add to cart (remove)
	5.	Topotecan: weighing in when there are many options. [electronic resource] by Penson, Richard T Seiden, Michael V Producer: 20060104 In: The oncologist vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Advanced APMs and the emerging role of immuno-oncology agents: balancing innovation and value. [electronic resource] by Seiden, Michael V Neubauer, Marcus Verrilli, Diana Producer: 20180716 In: The American journal of managed care vol. 23 Availability: No items available. Save to lists Add to cart (remove)
	7.	Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. [electronic resource] by Duan, Zhenfeng Brakora, Katherine A Seiden, Michael V Producer: 20050228 In: Molecular cancer therapeutics vol. 3 Availability: No items available. Save to lists Add to cart (remove)
	8.	MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines. [electronic resource] by Duan, Zhenfeng Brakora, Katherine A Seiden, Michael V Producer: 20041228 In: Gene vol. 340 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	cDNA Technologies and their application to drug resistance research: power, potential and problems. [electronic resource] by Duan, Zhenfeng Lamendola, Diana E Seiden, Michael V Publication details: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy Oct 2000 In: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location. [electronic resource] by Jain, Angela Ryan, Paula D Seiden, Michael V Producer: 20130307 In: Journal of the National Comprehensive Cancer Network : JNCCN vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies. [electronic resource] by Vaidya, Ami P Parnes, Aric D Seiden, Michael V Producer: 20050628 In: Current treatment options in oncology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles. [electronic resource] by Devalapally, Harikrishna Duan, Zhenfeng Seiden, Michael V Amiji, Mansoor M Producer: 20080818 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Case records of the Massachusetts General Hospital. Case 13-2007. A 46-year-old woman with gynecologic and intestinal cancers. [electronic resource] by Seiden, Michael V Patel, Devanshi O'Neill, Mary Jane Oliva, Esther Producer: 20070501 In: The New England journal of medicine vol. 356 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. [electronic resource] by Devalapally, Harikrishna Duan, Zhenfeng Seiden, Michael V Amiji, Mansoor M Producer: 20071029 In: International journal of cancer vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line. [electronic resource] by Lamendola, Diana E Duan, Zhenfeng Yusuf, Rushdia Z Seiden, Michael V Producer: 20030616 In: Cancer research vol. 63 Availability: No items available. Save to lists Add to cart (remove)
	16.	The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites. [electronic resource] by Cella, David Neubauer, Nikki Thomas, Jay Kutner, Jean Seiden, Michael V Producer: 20130325 In: Gynecologic oncology vol. 128 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. [electronic resource] by van Vlerken, Lilian E Duan, Zhenfeng Seiden, Michael V Amiji, Mansoor M Producer: 20070703 In: Cancer research vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines. [electronic resource] by Duan, Zhenfeng Lamendola, Diana E Duan, Yifei Yusuf, Rushdia Z Seiden, Michael V Producer: 20050216 In: Cancer chemotherapy and pharmacology vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	beta tubulin mutations are rare in human ovarian carcinoma. [electronic resource] by Lamendola, Diana E Duan, Zhenfeng Penson, Richard T Oliva, Esther Seiden, Michael V Producer: 20030417 In: Anticancer research vol. 23 Availability: No items available. Save to lists Add to cart (remove)
	20.	GBP1 overexpression is associated with a paclitaxel resistance phenotype. [electronic resource] by Duan, Zhenfeng Foster, Rosemary Brakora, Katherine A Yusuf, Rushdia Z Seiden, Michael V Producer: 20051223 In: Cancer chemotherapy and pharmacology vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 68 results.